PLOD1 and Hyperinsulinemia: Hyperinsulinemia increases serum free testosterone levels by reducing the production of hepatic sex hormone-binding globulin (SHBG), stimulates androgen production triggered by LH and insulin-like growth factor 1 (IGF-1), and enhances IGF-1 bioactivity by suppressing IGF-binding protein production [27].